← Leaderboards
Karen P. Beckerman
University Of California San Francisco
$564
Attributed
$564
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$564 · 1
By mechanism
M01$564 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Neal L Benowitz$31,329,042
- Diane W. Wara$7,985,315
- Susan J. Fisher$38,160,909
- Mark A Jacobson$6,824,928
- Reese T. Jones$7,250,168
Others in their field
Top investigators on “Aids Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$356,191,804
- Constance Ann Benson · University Of California, San Diego$277,003,036
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,875,323
- Barbara Driver · Westat, Inc.$205,980,213
- Sharon A Nachman · Johns Hopkins University$193,704,208
- Carol Nesel · Westat$188,148,170
Research focus
Aids TherapyAntiviral AgentsClinical ResearchEmbryo /Fetus Drug Adverse EffectEmbryo /Fetus PharmacologyFemaleHiv InfectionsHuman Pregnant SubjectHuman SubjectHuman Therapy EvaluationPharmacokineticsPregnancyVertical Transmission
Grant awards (6)
USE OF ANTIRETROVIRAL THERAPY DURING PREGNANCY$0
M01 · FY2002 · RR
USE OF ANTIRETROVIRAL THERAPY DURING PREGNANCY$0
M01 · FY2002 · RR
USE OF ANTIRETROVIRAL THERAPY DURING PREGNANCY$0
M01 · FY2001 · RR
USE OF ANTIRETROVIRAL THERAPY DURING PREGNANCY$564
M01 · FY2000 · RR
USE OF ANTIRETROVIRAL THERAPY DURING PREGNANCY$0
M01 · FY2000 · RR
USE OF ANTIRETROVIRAL THERAPY DURING PREGNANCY$0
M01 · FY2000 · RR